Structure (Atovaquone Oral Suspension 1)
Atovaquone Suspension
Product Images NDC 65162-693
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 65162-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Atovaquone Oral Suspension 2)
This is a description for a medication called Atovaquone Oral Suspension. The packaging comes in a 210mL container with a dosage of 750mg/5mL. The packaging insert provides information on dosage and administration. The suspension should not be frozen and must be dispensed in a tight container. The medication contains no more than 0.27% v/v of alcohol. The medicine should be stored at 15-25°C and should be shaken gently before using. The drug is distributed by Amneal Pharmaceuticals LLC, based in Bridgewater, NJ.*
Label (Atovaquone Oral Suspension 3)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
